1 Study Coverage 1.1 Chronic Heart Failure (CHF) Devices Product Introduction 1.2 Market by Type 1.2.1 Global Chronic Heart Failure (CHF) Devices Market Size Growth Rate by Type 1.4.2 Implantable Left Ventricular Assist Device (LVAD) 1.4.3 Biventricular Pacemaker 1.2.4 Implantable Cardioverter-defibrillators (ICDs) 1.2.5 Continuous Positive Air Pressure Device (CPAP) 1.2.6 Bi-level Positive Air Pressure Device (BiPAP) 1.2.7 Heart Pumps 1.3 Market by Application 1.3.1 Global Chronic Heart Failure (CHF) Devices Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Household 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Chronic Heart Failure (CHF) Devices Sales Estimates and Forecasts 2016-2027 2.2 Global Chronic Heart Failure (CHF) Devices Revenue Estimates and Forecasts 2016-2027 2.3 Global Chronic Heart Failure (CHF) Devices Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Chronic Heart Failure (CHF) Devices Regions by Sales 2.4.1 Global Top Chronic Heart Failure (CHF) Devices Regions by Sales (2016-2021) 2.4.2 Global Top Chronic Heart Failure (CHF) Devices Regions by Sales (2022-2027) 2.5 Global Top Chronic Heart Failure (CHF) Devices Regions by Revenue 2.5.1 Global Top Chronic Heart Failure (CHF) Devices Regions by Revenue (2016-2021) 2.5.2 Global Top Chronic Heart Failure (CHF) Devices Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Chronic Heart Failure (CHF) Devices Sales by Manufacturers 3.1.1 Global Top Chronic Heart Failure (CHF) Devices Manufacturers by Sales (2016-2021) 3.1.2 Global Top Chronic Heart Failure (CHF) Devices Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Chronic Heart Failure (CHF) Devices Sales in 2020 3.2 Global Chronic Heart Failure (CHF) Devices Revenue by Manufacturers 3.2.1 Global Top Chronic Heart Failure (CHF) Devices Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Chronic Heart Failure (CHF) Devices Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Chronic Heart Failure (CHF) Devices Revenue in 2020 3.3 Global Chronic Heart Failure (CHF) Devices Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Chronic Heart Failure (CHF) Devices Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Chronic Heart Failure (CHF) Devices Sales by Type 4.1.1 Global Chronic Heart Failure (CHF) Devices Historical Sales by Type (2016-2021) 4.1.2 Global Chronic Heart Failure (CHF) Devices Forecasted Sales by Type (2022-2027) 4.1.3 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) 4.2 Global Chronic Heart Failure (CHF) Devices Revenue by Type 4.2.1 Global Chronic Heart Failure (CHF) Devices Historical Revenue by Type (2016-2021) 4.2.2 Global Chronic Heart Failure (CHF) Devices Forecasted Revenue by Type (2022-2027) 4.2.3 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) 4.3 Global Chronic Heart Failure (CHF) Devices Price by Type 4.3.1 Global Chronic Heart Failure (CHF) Devices Price by Type (2016-2021) 4.3.2 Global Chronic Heart Failure (CHF) Devices Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Chronic Heart Failure (CHF) Devices Sales by Application 5.1.1 Global Chronic Heart Failure (CHF) Devices Historical Sales by Application (2016-2021) 5.1.2 Global Chronic Heart Failure (CHF) Devices Forecasted Sales by Application (2022-2027) 5.1.3 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) 5.2 Global Chronic Heart Failure (CHF) Devices Revenue by Application 5.2.1 Global Chronic Heart Failure (CHF) Devices Historical Revenue by Application (2016-2021) 5.2.2 Global Chronic Heart Failure (CHF) Devices Forecasted Revenue by Application (2022-2027) 5.2.3 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) 5.3 Global Chronic Heart Failure (CHF) Devices Price by Application 5.3.1 Global Chronic Heart Failure (CHF) Devices Price by Application (2016-2021) 5.3.2 Global Chronic Heart Failure (CHF) Devices Price Forecast by Application (2022-2027) 6 North America 6.1 North America Chronic Heart Failure (CHF) Devices Market Size by Type 6.1.1 North America Chronic Heart Failure (CHF) Devices Sales by Type (2016-2027) 6.1.2 North America Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2027) 6.2 North America Chronic Heart Failure (CHF) Devices Market Size by Application 6.2.1 North America Chronic Heart Failure (CHF) Devices Sales by Application (2016-2027) 6.2.2 North America Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2027) 6.3 North America Chronic Heart Failure (CHF) Devices Market Size by Country 6.3.1 North America Chronic Heart Failure (CHF) Devices Sales by Country (2016-2027) 6.3.2 North America Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Chronic Heart Failure (CHF) Devices Market Size by Type 7.1.1 Europe Chronic Heart Failure (CHF) Devices Sales by Type (2017-2027) 7.1.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Type (2017-2027) 7.2 Europe Chronic Heart Failure (CHF) Devices Market Size by Application 7.2.1 Europe Chronic Heart Failure (CHF) Devices Sales by Application (2017-2027) 7.2.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Application (2017-2027) 7.3 Europe Chronic Heart Failure (CHF) Devices Market Size by Country 7.3.1 Europe Chronic Heart Failure (CHF) Devices Sales by Country (2017-2027) 7.3.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Chronic Heart Failure (CHF) Devices Market Size by Type 8.1.1 Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Type (2018-2027) 8.1.2 Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Type (2018-2027) 8.2 Asia Pacific Chronic Heart Failure (CHF) Devices Market Size by Application 8.2.1 Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Application (2018-2027) 8.2.2 Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Application (2018-2027) 8.3 Asia Pacific Chronic Heart Failure (CHF) Devices Market Size by Region 8.3.1 Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region (2018-2027) 8.3.2 Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Chronic Heart Failure (CHF) Devices Market Size by Type 9.1.1 Latin America Chronic Heart Failure (CHF) Devices Sales by Type (2019-2027) 9.1.2 Latin America Chronic Heart Failure (CHF) Devices Revenue by Type (2019-2027) 9.2 Latin America Chronic Heart Failure (CHF) Devices Market Size by Application 9.2.1 Latin America Chronic Heart Failure (CHF) Devices Sales by Application (2019-2027) 9.2.2 Latin America Chronic Heart Failure (CHF) Devices Revenue by Application (2019-2027) 9.3 Latin America Chronic Heart Failure (CHF) Devices Market Size by Country 9.3.1 Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2019-2027) 9.3.2 Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Chronic Heart Failure (CHF) Devices Market Size by Type 6.1.1 Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Type (2016-2027) 6.1.2 Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2027) 6.2 Middle East and Africa Chronic Heart Failure (CHF) Devices Market Size by Application 6.2.1 Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Application (2016-2027) 6.2.2 Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2027) 6.3 Middle East and Africa Chronic Heart Failure (CHF) Devices Market Size by Country 6.3.1 Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Country (2016-2027) 6.3.2 Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 Medtronic 11.1.1 Medtronic Corporation Information 11.1.2 Medtronic Overview 11.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Medtronic Chronic Heart Failure (CHF) Devices Product Description 11.1.5 Medtronic Related Developments 11.2 Abbott 11.2.1 Abbott Corporation Information 11.2.2 Abbott Overview 11.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Abbott Chronic Heart Failure (CHF) Devices Product Description 11.2.5 Abbott Related Developments 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Corporation Information 11.3.2 Johnson & Johnson Overview 11.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Description 11.3.5 Johnson & Johnson Related Developments 11.4 Stanley Pharmaceuticals 11.4.1 Stanley Pharmaceuticals Corporation Information 11.4.2 Stanley Pharmaceuticals Overview 11.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Description 11.4.5 Stanley Pharmaceuticals Related Developments 11.5 New Haven Pharmaceuticals, Inc. 11.5.1 New Haven Pharmaceuticals, Inc. Corporation Information 11.5.2 New Haven Pharmaceuticals, Inc. Overview 11.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Description 11.5.5 New Haven Pharmaceuticals, Inc. Related Developments 11.6 Boston Scientific Corporation 11.6.1 Boston Scientific Corporation Corporation Information 11.6.2 Boston Scientific Corporation Overview 11.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Description 11.6.5 Boston Scientific Corporation Related Developments 11.7 HeartWare 11.7.1 HeartWare Corporation Information 11.7.2 HeartWare Overview 11.7.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 HeartWare Chronic Heart Failure (CHF) Devices Product Description 11.7.5 HeartWare Related Developments 11.8 Biovail Corporation 11.8.1 Biovail Corporation Corporation Information 11.8.2 Biovail Corporation Overview 11.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Biovail Corporation Chronic Heart Failure (CHF) Devices Product Description 11.8.5 Biovail Corporation Related Developments 11.9 Abiomed 11.9.1 Abiomed Corporation Information 11.9.2 Abiomed Overview 11.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Abiomed Chronic Heart Failure (CHF) Devices Product Description 11.9.5 Abiomed Related Developments 11.10 Symplmed Pharmaceuticals 11.10.1 Symplmed Pharmaceuticals Corporation Information 11.10.2 Symplmed Pharmaceuticals Overview 11.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Description 11.10.5 Symplmed Pharmaceuticals Related Developments 11.1 Medtronic 11.1.1 Medtronic Corporation Information 11.1.2 Medtronic Overview 11.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Medtronic Chronic Heart Failure (CHF) Devices Product Description 11.1.5 Medtronic Related Developments 11.12 ReliantHeart, Inc. 11.12.1 ReliantHeart, Inc. Corporation Information 11.12.2 ReliantHeart, Inc. Overview 11.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 ReliantHeart, Inc. Product Description 11.12.5 ReliantHeart, Inc. Related Developments 11.13 Cardiokinetix 11.13.1 Cardiokinetix Corporation Information 11.13.2 Cardiokinetix Overview 11.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Cardiokinetix Product Description 11.13.5 Cardiokinetix Related Developments 11.14 Biotronik 11.14.1 Biotronik Corporation Information 11.14.2 Biotronik Overview 11.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 Biotronik Product Description 11.14.5 Biotronik Related Developments 11.15 Jarvik Heart 11.15.1 Jarvik Heart Corporation Information 11.15.2 Jarvik Heart Overview 11.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 Jarvik Heart Product Description 11.15.5 Jarvik Heart Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Chronic Heart Failure (CHF) Devices Value Chain Analysis 12.2 Chronic Heart Failure (CHF) Devices Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Chronic Heart Failure (CHF) Devices Production Mode & Process 12.4 Chronic Heart Failure (CHF) Devices Sales and Marketing 12.4.1 Chronic Heart Failure (CHF) Devices Sales Channels 12.4.2 Chronic Heart Failure (CHF) Devices Distributors 12.5 Chronic Heart Failure (CHF) Devices Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Chronic Heart Failure (CHF) Devices Industry Trends 13.2 Chronic Heart Failure (CHF) Devices Market Drivers 13.3 Chronic Heart Failure (CHF) Devices Market Challenges 13.4 Chronic Heart Failure (CHF) Devices Market Restraints 14 Key Findings in The Global Chronic Heart Failure (CHF) Devices Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Chronic Heart Failure (CHF) Devices Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Implantable Left Ventricular Assist Device (LVAD) Table 3. Major Manufacturers of Biventricular Pacemaker Table 4. Major Manufacturers of Implantable Cardioverter-defibrillators (ICDs) Table 5. Major Manufacturers of Continuous Positive Air Pressure Device (CPAP) Table 6. Major Manufacturers of Bi-level Positive Air Pressure Device (BiPAP) Table 7. Major Manufacturers of Heart Pumps Table 8. Global Chronic Heart Failure (CHF) Devices Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 9. Global Chronic Heart Failure (CHF) Devices Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 10. Global Chronic Heart Failure (CHF) Devices Sales by Region (2016-2021) & (K Units) Table 11. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2016-2021) Table 12. Global Chronic Heart Failure (CHF) Devices Sales by Region (2016-2021) & (K Units) Table 13. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2022-2027) Table 14. Global Chronic Heart Failure (CHF) Devices Revenue by Region (2016-2021) & (US$ Million) Table 15. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2016-2021) Table 16. Global Chronic Heart Failure (CHF) Devices Revenue by Region (2022-2027) & (US$ Million) Table 17. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2022-2027) Table 18. Global Chronic Heart Failure (CHF) Devices Sales by Manufacturers (2016-2021) & (K Units) Table 19. Global Chronic Heart Failure (CHF) Devices Sales Share by Manufacturers (2016-2021) Table 20. Global Chronic Heart Failure (CHF) Devices Revenue by Manufacturers (2016-2021) & (US$ Million) Table 21. Global Chronic Heart Failure (CHF) Devices Revenue Share by Manufacturers (2016-2021) Table 22. Chronic Heart Failure (CHF) Devices Price by Manufacturers 2016-2021 (US$/Unit) Table 23. Global Chronic Heart Failure (CHF) Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 24. Global Chronic Heart Failure (CHF) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure (CHF) Devices as of 2020) Table 25. Chronic Heart Failure (CHF) Devices Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Chronic Heart Failure (CHF) Devices Product Offered Table 27. Date of Manufacturers Enter into Chronic Heart Failure (CHF) Devices Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Chronic Heart Failure (CHF) Devices Sales by Type (2016-2021) & (K Units) Table 30. Global Chronic Heart Failure (CHF) Devices Sales by Type (2022-2027) & (K Units) Table 31. Global Chronic Heart Failure (CHF) Devices Sales Share by Type (2016-2021) Table 32. Global Chronic Heart Failure (CHF) Devices Sales Share by Type (2022-2027) Table 33. Global Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2021) & (US$ Million) Table 34. Global Chronic Heart Failure (CHF) Devices Revenue by Type (2022-2027) & (US$ Million) Table 35. Global Chronic Heart Failure (CHF) Devices Revenue Share by Type (2016-2021) Table 36. Global Chronic Heart Failure (CHF) Devices Revenue Share by Type (2022-2027) Table 37. Chronic Heart Failure (CHF) Devices Price by Type (2016-2021) & (US$/Unit) Table 38. Global Chronic Heart Failure (CHF) Devices Price Forecast by Type (2022-2027) & (US$/Unit) Table 39. Global Chronic Heart Failure (CHF) Devices Sales by Application (2016-2021) & (K Units) Table 40. Global Chronic Heart Failure (CHF) Devices Sales by Application (2022-2027) & (K Units) Table 41. Global Chronic Heart Failure (CHF) Devices Sales Share by Application (2016-2021) Table 42. Global Chronic Heart Failure (CHF) Devices Sales Share by Application (2022-2027) Table 43. Global Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2021) & (US$ Million) Table 44. Global Chronic Heart Failure (CHF) Devices Revenue by Application (2022-2027) & (US$ Million) Table 45. Global Chronic Heart Failure (CHF) Devices Revenue Share by Application (2016-2021) Table 46. Global Chronic Heart Failure (CHF) Devices Revenue Share by Application (2022-2027) Table 47. Chronic Heart Failure (CHF) Devices Price by Application (2016-2021) & (US$/Unit) Table 48. Global Chronic Heart Failure (CHF) Devices Price Forecast by Application (2022-2027) & (US$/Unit) Table 49. North America Chronic Heart Failure (CHF) Devices Sales by Type (2016-2021) & (K Units) Table 50. North America Chronic Heart Failure (CHF) Devices Sales by Type (2022-2027) & (K Units) Table 51. North America Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2021) & (US$ Million) Table 52. North America Chronic Heart Failure (CHF) Devices Revenue by Type (2022-2027) & (US$ Million) Table 53. North America Chronic Heart Failure (CHF) Devices Sales by Application (2016-2021) & (K Units) Table 54. North America Chronic Heart Failure (CHF) Devices Sales by Application (2022-2027) & (K Units) Table 55. North America Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2021) & (US$ Million) Table 56. North America Chronic Heart Failure (CHF) Devices Revenue by Application (2022-2027) & (US$ Million) Table 57. North America Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units) Table 58. North America Chronic Heart Failure (CHF) Devices Sales by Country (2022-2027) & (K Units) Table 59. North America Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million) Table 60. North America Chronic Heart Failure (CHF) Devices Revenue by Country (2022-2027) & (US$ Million) Table 61. Europe Chronic Heart Failure (CHF) Devices Sales by Type (2016-2021) & (K Units) Table 62. Europe Chronic Heart Failure (CHF) Devices Sales by Type (2022-2027) & (K Units) Table 63. Europe Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2021) & (US$ Million) Table 64. Europe Chronic Heart Failure (CHF) Devices Revenue by Type (2022-2027) & (US$ Million) Table 65. Europe Chronic Heart Failure (CHF) Devices Sales by Application (2016-2021) & (K Units) Table 66. Europe Chronic Heart Failure (CHF) Devices Sales by Application (2022-2027) & (K Units) Table 67. Europe Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2021) & (US$ Million) Table 68. Europe Chronic Heart Failure (CHF) Devices Revenue by Application (2022-2027) & (US$ Million) Table 69. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units) Table 70. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2022-2027) & (K Units) Table 71. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million) Table 72. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2022-2027) & (US$ Million) Table 73. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Type (2016-2021) & (K Units) Table 74. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Type (2022-2027) & (K Units) Table 75. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2021) & (US$ Million) Table 76. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Type (2022-2027) & (US$ Million) Table 77. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Application (2016-2021) & (K Units) Table 78. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Application (2022-2027) & (K Units) Table 79. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2021) & (US$ Million) Table 80. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Application (2022-2027) & (US$ Million) Table 81. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region (2016-2021) & (K Units) Table 82. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region (2022-2027) & (K Units) Table 83. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2016-2021) & (US$ Million) Table 84. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2022-2027) & (US$ Million) Table 85. Latin America Chronic Heart Failure (CHF) Devices Sales by Type (2016-2021) & (K Units) Table 86. Latin America Chronic Heart Failure (CHF) Devices Sales by Type (2022-2027) & (K Units) Table 87. Latin America Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2021) & (US$ Million) Table 88. Latin America Chronic Heart Failure (CHF) Devices Revenue by Type (2022-2027) & (US$ Million) Table 89. Latin America Chronic Heart Failure (CHF) Devices Sales by Application (2016-2021) & (K Units) Table 90. Latin America Chronic Heart Failure (CHF) Devices Sales by Application (2022-2027) & (K Units) Table 91. Latin America Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2021) & (US$ Million) Table 92. Latin America Chronic Heart Failure (CHF) Devices Revenue by Application (2022-2027) & (US$ Million) Table 93. Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units) Table 94. Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2022-2027) & (K Units) Table 95. Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million) Table 96. Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2022-2027) & (US$ Million) Table 97. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Type (2016-2021) & (K Units) Table 98. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Type (2022-2027) & (K Units) Table 99. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Type (2016-2021) & (US$ Million) Table 100. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Type (2022-2027) & (US$ Million) Table 101. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Application (2016-2021) & (K Units) Table 102. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Application (2022-2027) & (K Units) Table 103. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Application (2016-2021) & (US$ Million) Table 104. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Application (2022-2027) & (US$ Million) Table 105. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Country (2016-2021) & (K Units) Table 106. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Country (2022-2027) & (K Units) Table 107. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2022-2027) & (US$ Million) Table 109. Medtronic Corporation Information Table 110. Medtronic Description and Major Businesses Table 111. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 112. Medtronic Chronic Heart Failure (CHF) Devices Product Table 113. Medtronic Recent Developments Table 114. Abbott Corporation Information Table 115. Abbott Description and Major Businesses Table 116. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. Abbott Chronic Heart Failure (CHF) Devices Product Table 118. Abbott Recent Developments Table 119. Johnson & Johnson Corporation Information Table 120. Johnson & Johnson Description and Major Businesses Table 121. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Table 123. Johnson & Johnson Recent Developments Table 124. Stanley Pharmaceuticals Corporation Information Table 125. Stanley Pharmaceuticals Description and Major Businesses Table 126. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Table 128. Stanley Pharmaceuticals Recent Developments Table 129. New Haven Pharmaceuticals, Inc. Corporation Information Table 130. New Haven Pharmaceuticals, Inc. Description and Major Businesses Table 131. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Table 133. New Haven Pharmaceuticals, Inc. Recent Developments Table 134. Boston Scientific Corporation Corporation Information Table 135. Boston Scientific Corporation Description and Major Businesses Table 136. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Table 138. Boston Scientific Corporation Recent Developments Table 139. HeartWare Corporation Information Table 140. HeartWare Description and Major Businesses Table 141. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. HeartWare Chronic Heart Failure (CHF) Devices Product Table 143. HeartWare Recent Developments Table 144. Biovail Corporation Corporation Information Table 145. Biovail Corporation Description and Major Businesses Table 146. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Biovail Corporation Chronic Heart Failure (CHF) Devices Product Table 148. Biovail Corporation Recent Developments Table 149. Abiomed Corporation Information Table 150. Abiomed Description and Major Businesses Table 151. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Abiomed Chronic Heart Failure (CHF) Devices Product Table 153. Abiomed Recent Developments Table 154. Symplmed Pharmaceuticals Corporation Information Table 155. Symplmed Pharmaceuticals Description and Major Businesses Table 156. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 157. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Table 158. Symplmed Pharmaceuticals Recent Developments Table 159. Berlin Heart GmbH Corporation Information Table 160. Berlin Heart GmbH Description and Major Businesses Table 161. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 162. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Table 163. Berlin Heart GmbH Recent Developments Table 164. ReliantHeart, Inc. Corporation Information Table 165. ReliantHeart, Inc. Description and Major Businesses Table 166. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 167. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Table 168. ReliantHeart, Inc. Recent Developments Table 169. Cardiokinetix Corporation Information Table 170. Cardiokinetix Description and Major Businesses Table 171. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 172. Cardiokinetix Chronic Heart Failure (CHF) Devices Product Table 173. Cardiokinetix Recent Developments Table 174. Biotronik Corporation Information Table 175. Biotronik Description and Major Businesses Table 176. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 177. Biotronik Chronic Heart Failure (CHF) Devices Product Table 178. Biotronik Recent Developments Table 179. Jarvik Heart Corporation Information Table 180. Jarvik Heart Description and Major Businesses Table 181. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 182. Jarvik Heart Chronic Heart Failure (CHF) Devices Product Table 183. Jarvik Heart Recent Developments Table 184. Key Raw Materials Lists Table 185. Raw Materials Key Suppliers Lists Table 186. Chronic Heart Failure (CHF) Devices Distributors List Table 187. Chronic Heart Failure (CHF) Devices Customers List Table 188. Chronic Heart Failure (CHF) Devices Market Trends Table 189. Chronic Heart Failure (CHF) Devices Market Drivers Table 190. Chronic Heart Failure (CHF) Devices Market Challenges Table 191. Chronic Heart Failure (CHF) Devices Market Restraints Table 192. Research Programs/Design for This Report Table 193. Key Data Information from Secondary Sources Table 194. Key Data Information from Primary Sources List of Figures Figure 1. Chronic Heart Failure (CHF) Devices Product Picture Figure 2. Global Chronic Heart Failure (CHF) Devices Market Share by Type in 2020 & 2027 Figure 3. Implantable Left Ventricular Assist Device (LVAD) Product Picture Figure 4. Biventricular Pacemaker Product Picture Figure 5. Implantable Cardioverter-defibrillators (ICDs) Product Picture Figure 6. Continuous Positive Air Pressure Device (CPAP) Product Picture Figure 7. Bi-level Positive Air Pressure Device (BiPAP) Product Picture Figure 8. Heart Pumps Product Picture Figure 9. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application in 2020 & 2027 Figure 10. Hospital Figure 11. Clinic Figure 12. Household Figure 13. Others Figure 14. Chronic Heart Failure (CHF) Devices Report Years Considered Figure 15. Global Chronic Heart Failure (CHF) Devices Sales 2016-2027 (K Units) Figure 16. Global Chronic Heart Failure (CHF) Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Chronic Heart Failure (CHF) Devices Revenue 2016-2027 (US$ Million) Figure 18. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 19. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2016-2021) Figure 20. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2022-2027) Figure 21. North America Chronic Heart Failure (CHF) Devices Sales YoY (2016-2027) & (K Units) Figure 22. North America Chronic Heart Failure (CHF) Devices Revenue YoY (2016-2027) & (US$ Million) Figure 23. Europe Chronic Heart Failure (CHF) Devices Sales YoY (2016-2027) & (K Units) Figure 24. Europe Chronic Heart Failure (CHF) Devices Revenue YoY (2016-2027) & (US$ Million) Figure 25. Asia-Pacific Chronic Heart Failure (CHF) Devices Sales YoY (2016-2027) & (K Units) Figure 26. Asia-Pacific Chronic Heart Failure (CHF) Devices Revenue YoY (2016-2027) & (US$ Million) Figure 27. Latin America Chronic Heart Failure (CHF) Devices Sales YoY (2016-2027) & (K Units) Figure 28. Latin America Chronic Heart Failure (CHF) Devices Revenue YoY (2016-2027) & (US$ Million) Figure 29. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales YoY (2016-2027) & (K Units) Figure 30. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue YoY (2016-2027) & (US$ Million) Figure 31. The Top 10 and Top 5 Players Market Share by Chronic Heart Failure (CHF) Devices Sales in 2020 Figure 32. The Top 10 and Top 5 Players Market Share by Chronic Heart Failure (CHF) Devices Revenue in 2020 Figure 33. Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 34. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) Figure 35. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) Figure 36. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) Figure 37. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) Figure 38. North America Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) Figure 39. North America Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) Figure 40. North America Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) Figure 41. North America Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) Figure 42. North America Chronic Heart Failure (CHF) Devices Sales Share by Country (2016-2027) Figure 43. North America Chronic Heart Failure (CHF) Devices Revenue Share by Country (2016-2027) Figure 44. U.S. Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 45. Canada Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 46. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) Figure 47. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) Figure 48. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) Figure 49. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) Figure 50. Europe Chronic Heart Failure (CHF) Devices Sales Share by Country (2016-2027) Figure 51. Europe Chronic Heart Failure (CHF) Devices Revenue Share by Country (2016-2027) Figure 52. Germany Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 53. France Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 54. U.K. Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 55. Italy Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 56. Russia Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 57. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) Figure 58. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) Figure 59. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) Figure 60. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) Figure 61. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Share by Region (2016-2027) Figure 62. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue Share by Region (2016-2027) Figure 63. China Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 64. Japan Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 65. South Korea Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 66. India Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 67. Australia Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 68. Taiwan Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 69. Indonesia Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 70. Thailand Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 71. Malaysia Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 72. Philippines Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 73. Latin America Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) Figure 74. Latin America Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) Figure 75. Latin America Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) Figure 76. Latin America Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) Figure 77. Latin America Chronic Heart Failure (CHF) Devices Sales Share by Country (2016-2027) Figure 78. Latin America Chronic Heart Failure (CHF) Devices Revenue Share by Country (2016-2027) Figure 79. Mexico Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 80. Brazil Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 81. Argentina Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 82. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2016-2027) Figure 83. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2016-2027) Figure 84. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2016-2027) Figure 85. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2016-2027) Figure 86. Middle East and Africa Chronic Heart Failure (CHF) Devices Sales Share by Country (2016-2027) Figure 87. Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue Share by Country (2016-2027) Figure 88. Turkey Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 89. Saudi Arabia Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 90. UAE Chronic Heart Failure (CHF) Devices Revenue (2016-2027) & (US$ Million) Figure 91. Chronic Heart Failure (CHF) Devices Value Chain Figure 92. Chronic Heart Failure (CHF) Devices Production Process Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed

Medtronic Abbott Johnson & Johnson Stanley Pharmaceuticals New Haven Pharmaceuticals, Inc. Boston Scientific Corporation HeartWare Biovail Corporation Abiomed Symplmed Pharmaceuticals Berlin Heart GmbH ReliantHeart, Inc. Cardiokinetix Biotronik Jarvik Heart